|
FDA Approval Activities for this Drug
Dalmane (flurazepam hydrochloride) Capsules, 15 mg and 30 mg ICN NDA 16-721/S-074 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Geneva 071717 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Geneva 016721 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG DALMANE ICN
016721 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG DALMANE ICN
070344 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Mylan
070345 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Mylan
070444 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Par 070445 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Par 071205 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Watson 072369 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Watson 071068 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Watson 071107 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL West Ward
071108 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL West Ward
For the most up-to-date approval information, please locate this API using the drug index.
|